HTSUF Stock Price, Chart, Stats & News
Hisamitsu Pharmaceutical Co., Inc. (HTSUF) is a dividend-paying stock with a current dividend yield of 4.25% as of Sep 26, 2025. It pays $1.23 per share over the trailing twelve months and distributes quarterly. Its dividend has grown at a 9.34% 5-year compound annual rate.
Dividend safety
Dividend coverage is moderate for HTSUF — it pays out about 69% of earnings.
HTSUF chart
About
Hisamitsu Pharmaceutical Co., Inc. is a Japanese enterprise that develops and markets a range of pharmaceuticals, quasi-drugs, and medical devices. Its extensive product catalog includes popular external pain relief solutions such as SALONPAS, NOBINOBI, SALONSIP, AIR, and FEITAS. The company also provides targeted treatments like BUTENALOCK for athlete's foot and ALLEGRA FX, a medication addressing sinus and allergy symptoms.
Related lists
Similar securities
Based on sector and market capitalization
